Abstract
BackgroundComprehensive profiling of autoantibodies (AAbs) in metastatic urothelial cancer (mUC) has not been performed to date. This may aid in diagnosis of UC, uncover novel therapeutic targets in this disease...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have